The latest closing stock price for Cartesian Therapeutics as of September 19, 2024 is 16.54.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-961 today, roughly -1 times their original investment - a -33.26% compound annual growth rate over 8 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 42.64, which is 157.8% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 11.66, which is 29.5% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 23.02.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-961 today, roughly -1 times their original investment - a -33.26% compound annual growth rate over 8 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 42.64, which is 157.8% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 11.66, which is 29.5% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 23.02.